FMP
Vera Therapeutics, Inc.
VERA
NASDAQ
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
39.52 USD
0.39 (0.987%)
About
ceo
Dr. Marshall W. Fordyce M.D.
sector
Healthcare
industry
Biotechnology
website
https://veratx.com
exchange
NASDAQ
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartere...
CIK
0001831828
ISIN
US92337R1014
CUSIP
92337R101
Address
8000 Marina Boulevard
Phone
650 770 0077
Country
US
Employee
51
IPO Date
May 14, 2021
Summary
CIK
0001831828
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
92337R101
ISIN
US92337R1014
Country
US
Price
39.52
Beta
1.05
Volume Avg.
1.42M
Market Cap
2.17B
Shares
-
52-Week
6.07-50.78
DCF
-0.19
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-17.56
P/B
-
Website
https://veratx.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest VERA News
It looks like there's no news available.
